赛生药业(06600):12.25万份购股权获行使

智通财经
May 13, 2024

智通财经APP讯,赛生药业(06600)发布公告,于2024年5月13日,根据首次公开发售后购股权计划授出的12.25万份购股权已根据首次公开发售后购股权计划的规则获行使。

截至本公告日期,公司所发行有关证券的所有类别及该等已发行及发行在外证券的数目详情如下:因上文所载行使首次公开发售后购股权计划项下授出的购股权而发行12.25万股新股份后,合共6.29亿股已发行股份;及紧随上文所载行使购股权后,合共6761.85万份购股权。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10